Search - tctmd.com

Displaying 501 - 520 of 636

Sort: Relevancy | Date

News Daily News

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

Yael L. Maxwell

May 17, 2013

News Daily News

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Yael L. Maxwell

May 17, 2013

News Industry News

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

May 17, 2013

Presentation

PROTECT AF: The Mortality Effects of LAA Closure vs. Warfarin for Stroke Prophylaxis in A-fib

Presenter: Vivek Y. Reddy

May 14, 2013

News Industry News

New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The P

May 09, 2013

Presentation Fellows 2013

LAA Closure for Nonvalvular Atrial Fibrillation

Presenter: Mark Reisman

April 17, 2013

News Daily News

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

Yael L. Maxwell

April 12, 2013

News Daily News

ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina

Yael L. Maxwell

April 12, 2013

Presentation

LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation

Presenter: Vivek Y. Reddy

April 09, 2013

Presentation ECHO 2013

Quantifying the Left Heart (LV and LA): Basic and Advanced Measurements

Presenter: Omar Khalique

April 03, 2013

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

Presentation

Post ACC Wrap-up: PREVAIL and PARTNER II

Presenter: Gregg W. Stone

March 13, 2013

News Conference News ACC 2013

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Yael L. Maxwell

March 08, 2013

Presentation ACC 2013

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Presenter: David R. Holmes, Jr.

March 08, 2013

News Daily News

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Jason Kahn

February 28, 2013

News Daily News

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

Jason Kahn

February 28, 2013

Presentation

Quality-of-Life Assessment in the Randomized PROTECT AF Trial of Patients at Risk for Stroke with Nonvalvular A-fib

Presenter: 147572|Oluseun Alli

February 27, 2013

Presentation TCT 2013

Safety and Biocompatibility of the Coherex WaveCrest[sup]TM[/sup] Left Atrial Appendage Occluder in a 30-Day Canine Study

Presenter: Yanping Cheng, Jenn McGregor, Robert Sommer, William Gray, Daryl Edmiston, Gerard Conditt, Genghua Yi, Armando Tellez, Serge Rousselle, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Impact of left atrial appendage occlusion, with percutaneous device on left atrial function

Presenter: Pedro Almeida, Eduardo Infante de Oliveira, Jo?o Marques, Fernando Ribeiro, Pedro Canas Silva, Ant?nio Nunes Diogo, Fausto Pinto

January 31, 2013

Presentation TCT 2013

First In-Vivo Evaluation of the Ultrasept Left Atrial Appendage Closure Device

Presenter: Yanping Cheng, Gerard Conditt, Genghua Yi, Alyssa Wagner, Patricia Mount, Armando Tellez, Serge Rousselle, Greg Kaluza, Juan Granada

January 31, 2013

Advertisement

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

PROTECT AF: The Mortality Effects of LAA Closure vs. Warfarin for Stroke Prophylaxis in A-fib

New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The P

LAA Closure for Nonvalvular Atrial Fibrillation

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina

LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation

Quantifying the Left Heart (LV and LA): Basic and Advanced Measurements

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

Post ACC Wrap-up: PREVAIL and PARTNER II

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

Quality-of-Life Assessment in the Randomized PROTECT AF Trial of Patients at Risk for Stroke with Nonvalvular A-fib

Safety and Biocompatibility of the Coherex WaveCrest[sup]TM[/sup] Left Atrial Appendage Occluder in a 30-Day Canine Study

Impact of left atrial appendage occlusion, with percutaneous device on left atrial function

First In-Vivo Evaluation of the Ultrasept Left Atrial Appendage Closure Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content